India, June 16 -- Godavari Biorefineries announced that the Japanese Patent Office has granted its patent, 5-HYDROXY 1,4-NAPHTHALENEDIONE FOR USE IN THE TREATMENT OF CANCER.This patent covers a novel class of compounds that exhibit strong inhibitory effects on cancer and cancer stem cells, demonstrating significant efficacy against multiple types, including breast and prostate cancer.
Published by HT Digital Content Services with permission from Pivotal Sources....